Expired50% confidenceEventExact time
AI pharmaceutical company Xunming Biosciences completed a Series B financing round totaling $100 million.
1
Sources
50%
Confidence
Short-term (~14 days)
Relevance
8/30/2026
First Seen
This claim has expired. It is kept for the record and no longer describes the current state.
Valid until: 9/13/2026(expired)
Sources
Related Entities
Related Claims
UnverifiedParis-based AI voice startup Gradium has closed a $100 million seed funding round.72% similarUnverifiedMeta has offered AI researchers signing bonuses approaching $100 million and total three-year compensation packages as high as $400 million.71% similarUnverifiedAI应用生成平台Lovable宣布完成4亿美元C轮融资70% similarUnverifiedCurrent AI has secured committed funding of up to $400 million.68% similarUnverifiedThe project iterated through 3 major versions and over 100 minor versions within one month, with a cash outlay of approximately several hundred USD spent mainly on AI subscriptions and asset generation.65% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/825439API
curl https://kongchang.com/api/v1/knowledge/claims/825439MCP
get_claim(id=825439)